ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676334 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676334; 2) Community: the network communities that were significantly associated with the response to NSC 676334; 3) Molecule: the relationships between components within communities and NSC 676334; 4) MDR: the compounds that were significantly associated with the NSC 676334.

NSC Compound Enrichment Correlation
NSC 609699 Topotecan hydrochloride 0.0287337488682932 0.079290822
NSC 610459 Camptothecin Derivative 0.0287337488682932 0.017557645
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0287337488682932 -0.084471517
NSC 639186 Raltitrexed 0.0287337488682932 -0.050260979
NSC 640499 2,2':6',2"-Terpyridine, 4'-[4-(2-hydroxyethoxy)phenyl]- 0.0287337488682932 -0.22189862
NSC 644960 Null 0.0287337488682932 -0.18654227
NSC 653860 Null 0.0287337488682932 0.16026249
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.0287337488682932 0.16381261
NSC 664314 Null 0.0287337488682932 0.22119562
NSC 666220 Null 0.0287337488682932 0.04020832
Total:63  Current:38    [First] [Prev] [Next] [Last]